<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00245141</url>
  </required_header>
  <id_info>
    <org_study_id>JRSG-UHA-PED03-01</org_study_id>
    <secondary_id>CDR0000453316</secondary_id>
    <nct_id>NCT00245141</nct_id>
  </id_info>
  <brief_title>Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma</brief_title>
  <official_title>Phase II Trial of Short VAC1.2 Therapy for Low-Risk A Group Patients With Rhabdomyosarcoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japan Rhabdomyosarcoma Study Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Drugs used in chemotherapy, such as vincristine, dactinomycin, and
      cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing
      the cells or by stopping them from dividing. Radiation therapy uses high energy x-rays to
      kill tumor cells. Giving more than one drug (combination chemotherapy) with radiation therapy
      may kill more tumor cells.

      PURPOSE: This phase II trial is studying how well giving vincristine, dactinomycin, and
      cyclophosphamide together with or without radiation therapy works in treating patients with
      embryonal rhabdomyosarcoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Determine the progression-free survival rate in patients with low-risk embryonal
           rhadomyosarcoma treated with a shortened treatment schedule of vincristine,
           dactinomycin, and cyclophosphamide with or without radiotherapy.

      OUTLINE: Patients receive vincristine IV, dactinomycin IV, and cyclophosphamide IV. Patients
      may also undergo radiotherapy. Treatment repeats every 3 weeks for up to 8 courses (total of
      24 weeks) in the absence of disease progression or unacceptable toxicity.

      PROJECTED ACCRUAL: A total of 32 patients will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2004</start_date>
  <primary_completion_date type="Anticipated">April 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free survival as measured by Kaplan-Meier method 3 years after study entry</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival as measured by Kaplan-Meier method 3 years after study entry</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival as measured by Kaplan-Meier method during events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete response rate (orbit, group III only) at completion of study treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of toxicity as measured by NCI-CTC v 2.0 3 years after study entry</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Sarcoma</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>dactinomycin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cyclophosphamide</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vincristine sulfate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Diagnosis of embryonal rhabdomyosarcoma

               -  Primary operation for pathological diagnosis within the past 42 days

               -  The following variants are eligible:

                    -  Botryoid

                    -  Spindle cell

                    -  Anaplastic

          -  Meets 1 of the following stage criteria:

               -  Stage I, clinical group I or II (N0), defined by all of the following criteria:

                    -  Favorable site, including orbit, head, and neck (excluding parameningeal
                       sites), genitourinary region (excluding bladder/prostate sites), or biliary
                       tract

                    -  Tumor any size

                    -  Completely resected disease OR microscopic residual disease

                    -  Lymph nodes clinically negative

               -  Stage I, clinical group III (N0), defined by all of the following criteria:

                    -  Favorable site

                    -  Tumor any size

                    -  Gross residual disease allowed (orbit only)

                    -  Lymph nodes clinically negative

               -  Stage II, clinical group I (N0, Nx), defined by all of the following criteria:

                    -  Unfavorable site (any sites not listed as favorable sites)

                    -  Tumor ≤ 5 cm in diameter

                    -  Completely resected disease

                    -  Lymph nodes clinically negative OR lymph node involvement unknown

        PATIENT CHARACTERISTICS:

        Performance status

          -  0-3

        Life expectancy

          -  Not specified

        Hematopoietic

          -  WBC ≥ 2,000/mm^3

          -  Platelet count ≥ 100,000/mm^3

          -  Hemoglobin ≥ 7.5 g/dL

        Hepatic

          -  SGOT and SGPT ≤ 2.5 times upper limit of normal (ULN)

          -  Bilirubin ≤ 2.5 times ULN

          -  Bile acid ≤ 2.5 times ULN

        Renal

          -  Creatinine based on age as follows:

               -  &lt; 0.8 mg/dL (for patients &lt; 5 years of age)

               -  &lt; 1.2 mg/dL (for patients 5-9 years of age)

               -  &lt; 1.5 mg/dL (for patients ≥ 10 years of age)

        Cardiovascular

          -  No severe heart disease

        Other

          -  Not pregnant or nursing

          -  Must have acceptable organ function for age

          -  No uncontrolled infection

          -  No other active malignancy

          -  No other treated malignancy within the past 5 years

          -  No hypersensitivity to study drugs

          -  No Charcot-Marie-Tooth disease

          -  No chickenpox

        PRIOR CONCURRENT THERAPY:

        Chemotherapy

          -  No prior anticancer chemotherapy

        Endocrine therapy

          -  Prior anticancer steroids allowed

        Radiotherapy

          -  No prior radiotherapy

        Other

          -  No concurrent pentostatin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hajime Hosoi</last_name>
    <role>Study Chair</role>
    <affiliation>Kyoto Prefectural University of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masa-aki Kumagai, MD</last_name>
    <affiliation>National Center for Child Health and Development</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anjo Kosei Hosptial</name>
      <address>
        <city>Anjo</city>
        <state>Aichi</state>
        <zip>446-8602</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuji Miyajima, MD</last_name>
      <phone>81-566-75-2111</phone>
      <email>miyajima@kosei.anjo.aichi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aichi Medical University</name>
      <address>
        <city>Nagakuti</city>
        <state>Aichi</state>
        <zip>480-1103</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toshinori Hori</last_name>
      <phone>81-561-62-3311</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital Orgnization Nagoya Medical Center</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>460-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keizo Horibe, MD, PhD</last_name>
      <phone>81-52-951-1111</phone>
      <email>horibek@nnh.hosp.go.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ehime Prefectural Central Hospital</name>
      <address>
        <city>Matsuyama-shi</city>
        <state>Ehime</state>
        <zip>790-0024</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Otoh Yoshiko</last_name>
      <phone>81-89-947-1111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Kyushu Cancer Center</name>
      <address>
        <city>Fukuoka-shi</city>
        <state>Fukuoka</state>
        <zip>811-1395</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryohei Yokoyama, MD</last_name>
      <phone>81-92-541-3231 ext. 5070</phone>
      <email>ryokoya@nk-cc.go.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kurume University School of Medicine</name>
      <address>
        <city>Kurume City</city>
        <state>Fukuoka</state>
        <zip>830-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroko Inada</last_name>
      <phone>81-942-31-7565</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gifu Municipal Hospital</name>
      <address>
        <city>Gifu-shi</city>
        <state>Gifu</state>
        <zip>500-8513</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akira Takao, MD</last_name>
      <phone>81-58-251-1101</phone>
      <email>oyuki@gmhosp.gifu.gifu.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gunma Children's Medical Center</name>
      <address>
        <city>Seta-gun</city>
        <state>Gunma</state>
        <zip>377-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manabu Sotomatsu, MD</last_name>
      <phone>81-279-52-3551</phone>
      <email>sotomatsu@gcmc.pref.gunma.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization - Medical Center of Kure</name>
      <address>
        <city>Kure</city>
        <state>Hiroshima</state>
        <zip>737-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takeo Tanaka, MD, PhD</last_name>
      <phone>81-82-322-3111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sapporo Medical University</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nobuhiro Suzuki, MD, PhD</last_name>
      <phone>81-11-611-2111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hokkaido University Graduate School of Medicine</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-8638</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryoji Kobayashi, MD</last_name>
      <phone>81-11-706-5954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kobe City General Hospital</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>650</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ikuya Usami</last_name>
      <phone>81-78-302-4321</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ibaraki Children's Hospital</name>
      <address>
        <city>Mito-shi</city>
        <state>Ibaraki</state>
        <zip>311-4145</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazutoshi Koike</last_name>
      <phone>81-29-254-1151</phone>
      <email>kazukoike@ibaraki-kodomo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tsukuba</name>
      <address>
        <city>Tsukuba-city</city>
        <state>Ibaraki</state>
        <zip>305-8575</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michio Kaneko, MD, PhD</last_name>
      <phone>81-29-853-3094</phone>
      <email>mkaneko@md.tsukuba.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ishikawa Prefectural Central Hospital</name>
      <address>
        <city>Kanazawa-shi</city>
        <state>Ishikawa</state>
        <zip>920-02</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seiki Horita</last_name>
      <phone>81-76-237-8211</phone>
      <email>shorita@ipch.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kanazawa Medical University</name>
      <address>
        <city>Kanazawa</city>
        <state>Ishikawa</state>
        <zip>920-8641</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yutaka Saikawa, MD, PhD</last_name>
      <phone>81-76-265-2314</phone>
      <email>saikawa@ped.m.kanazawa-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kagoshima City Hospital</name>
      <address>
        <city>Kagoshima City</city>
        <state>Kagoshima</state>
        <zip>892-8580</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kiyoshi Kawakami</last_name>
      <phone>81-99-224-2101</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Center for Child Health and Development</name>
      <address>
        <city>Tokyo</city>
        <state>Kanagawa</state>
        <zip>157-8535</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masa-aki Kumagai, MD</last_name>
      <phone>81-3-3416-0181</phone>
      <email>kumagai-ma@ncchd.go.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Showa University Fujigaoka Hospital</name>
      <address>
        <city>Yokohama-shi</city>
        <state>Kanagawa</state>
        <zip>227-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>K. Isoyama</last_name>
      <phone>81-45-971-1151</phone>
      <email>isoyama@syowa-univesity-fujigaoka.gr.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yokohama City University</name>
      <address>
        <city>Yokohama</city>
        <state>Kanagawa</state>
        <zip>236-0004</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroaki Goto</last_name>
      <phone>81-45-787-2800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Miyazaki Medical College University of Miyazaki</name>
      <address>
        <city>Miyazaki-gun</city>
        <state>Miyazaki</state>
        <zip>889-1692</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroshi Moritake</last_name>
      <phone>81-98-585-0989</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nagano Children's Hospital</name>
      <address>
        <city>Toyoshina-machi</city>
        <state>Nagano</state>
        <zip>399-8288</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eizaburo Ishii</last_name>
      <phone>81-263-73-6700</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka Medical Center and Research Institute for Maternal and Child Health</name>
      <address>
        <city>Izumi</city>
        <state>Osaka</state>
        <zip>594-1101</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keisei Kawa, MD, PhD</last_name>
      <phone>81-725-56-1220</phone>
      <email>kawakei@mch.pref.osaka.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka City General Hospital</name>
      <address>
        <city>Suita-shi</city>
        <state>Osaka</state>
        <zip>565-0871</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junichi Hara</last_name>
      <phone>81-6-6929-1221</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka University Graduate School of Medicine</name>
      <address>
        <city>Suita-shi</city>
        <state>Osaka</state>
        <zip>565-0871</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hideaki Ohta, MD, PhD</last_name>
      <phone>81-6-6879-3937</phone>
      <email>ohta@ped.med.osaka-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka Medical College</name>
      <address>
        <city>Takatsuki City</city>
        <state>Osaka</state>
        <zip>569-8686</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomoko Kuno</last_name>
      <phone>81-72-683-1221</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dokkyo University School of Medicine</name>
      <address>
        <city>Koshigaya</city>
        <state>Saitama</state>
        <zip>343-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hitoshi Ikeda, MD</last_name>
      <phone>81-489-65-1111</phone>
      <email>hike@dokkyomed.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Defense Medical College</name>
      <address>
        <city>Tokorozawa</city>
        <state>Saitama</state>
        <zip>359-8513</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazuhiro Kogawa</last_name>
      <phone>81-4-2995-1621</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shiga University of Medical Science</name>
      <address>
        <city>Otsu-shi</city>
        <state>Shiga</state>
        <zip>520-21</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shigeru Ohta, MD</last_name>
      <phone>81-775-48-2228</phone>
      <email>ohta@belle.shiga-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shimane Prefectural Central Hospital</name>
      <address>
        <city>Izumo</city>
        <state>Shimane</state>
        <zip>693-0068</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ken Taketani, MD</last_name>
      <phone>81-853-20-2219</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shimane University Hospital</name>
      <address>
        <city>Izumo</city>
        <state>Shimane</state>
        <zip>693-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ken Taketani, MD</last_name>
      <phone>81-853-20-2219</phone>
      <email>ttaketani@med.shimane-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seirei Hamamatsu General Hospital</name>
      <address>
        <city>Hamamatsu</city>
        <state>Shizuoka</state>
        <zip>430-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tadashi Matsubayashi</last_name>
      <phone>81-53-474-2222</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Metropolitan Kiyose Children's Hospital</name>
      <address>
        <city>Kiyosei</city>
        <state>Tokyo</state>
        <zip>204-8567</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takashi Kaneko, MD</last_name>
      <phone>81-424-91-0011</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fukushima Medical University Hospital</name>
      <address>
        <city>Fukushima</city>
        <zip>960-1295</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atsushi Kikuta, MD</last_name>
      <phone>81-24-547-1295</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gifu University Graduate School of Medicine</name>
      <address>
        <city>Gifu</city>
        <zip>500-8705</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hideo Kaneko</last_name>
      <phone>81-58-230-6386</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hiroshima University Hospital</name>
      <address>
        <city>Hiroshima</city>
        <zip>734-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nishimura Shinichiro, MD</last_name>
      <phone>81-82-257-5212</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kagoshima University</name>
      <address>
        <city>Kagoshima</city>
        <zip>890-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoshifumi Kawano</last_name>
      <phone>81-99-275-5351</phone>
      <email>ykawano@m3.kufm.kagoshima-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyoto Prefectural University of Medicine</name>
      <address>
        <city>Kyoto</city>
        <zip>602-8566</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hajime Hosoi</last_name>
      <phone>81-75-251-5571</phone>
      <email>hhosoi@koto.kpu-m.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>606-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenichiro Watanabe, MD</last_name>
      <phone>81-75-751-3297</phone>
      <email>wataken@kuhp.kyoto-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka City University</name>
      <address>
        <city>Osaka</city>
        <zip>545-8586</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kazumi Yamato</last_name>
      <phone>81-6-6645-3175</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Osaka General Medical Center</name>
      <address>
        <city>Osaka</city>
        <zip>558-0056</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keiko Yumura-Yagi, MD</last_name>
      <phone>81-6-6692-1201</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saitama Children's Medical Center</name>
      <address>
        <city>Saitama</city>
        <zip>339-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akira Kikuchi, MD, PhD</last_name>
      <phone>81-48-758-1811</phone>
      <email>a1091069@pref.saitama.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hokkaido Medical Center for Child Health and Rehabilitation</name>
      <address>
        <city>Sapporo</city>
        <zip>006-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tooru Kudoh, MD, PhD</last_name>
      <phone>81-11-691-5696</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atsushi Makimoto</last_name>
      <phone>81-3-3542-2511</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Luke's International Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>104</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Hosoya, MD</last_name>
      <phone>81-3-3541-5151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical and Dental University</name>
      <address>
        <city>Tokyo</city>
        <zip>113-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masayuki Nagasawa</last_name>
      <phone>81-3-5803-5246</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toho University School of Medicine</name>
      <address>
        <city>Tokyo</city>
        <zip>143-8541</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akira Ohara</last_name>
      <phone>81-3-3762-4151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Keio University School of Medicine</name>
      <address>
        <city>Tokyo</city>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasuhide Morikawa, MD</last_name>
      <phone>81-3-5363-2593</phone>
      <email>ymorikaw@sc.itc.keio.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nihon University Itabashi Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>173</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hideo Mugishima, MD</last_name>
      <phone>81-3-3972-8111 ext. 2700</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toyama University Hospital</name>
      <address>
        <city>Toyama</city>
        <zip>930-0194</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hirokazu Kanegane</last_name>
      <phone>81-76-434-7313</phone>
      <email>kanegane@ms.toyama-mpu.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yamagata University Hospital</name>
      <address>
        <city>Yamagata</city>
        <zip>990-9585</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitsui Tetsuo, MD, DMedSci</last_name>
      <phone>81-23-628-5329</phone>
      <email>tmitsui@med.id.yamagata-u.ac.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2005</study_first_submitted>
  <study_first_submitted_qc>October 25, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2005</study_first_posted>
  <last_update_submitted>August 9, 2013</last_update_submitted>
  <last_update_submitted_qc>August 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <keyword>embryonal childhood rhabdomyosarcoma</keyword>
  <keyword>embryonal-botryoid childhood rhabdomyosarcoma</keyword>
  <keyword>previously untreated childhood rhabdomyosarcoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhabdomyosarcoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Vincristine</mesh_term>
    <mesh_term>Dactinomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

